Is health screening beneficial for early detection and prognostic improvement in pancreatic cancer?

Gut and Liver

Volumn 5, Issue 2, 2011, Pages 194-199

  Kim, Eun Ran ^a   Bae, Sun Youn ^a   Lee, Kwang Hyuk ^a   Lee, Kyu Taek ^a   Son, Hee Jung ^a   Rhee, Jong Chul ^a   Lee, Jong Kyun ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Early detection; Pancreatic cancer; Prognosis; Screening

Indexed keywords

CA 19-9 ANTIGEN;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADULT; AGED; ANOREXIA; ARTICLE; BACKACHE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER PATIENT; CANCER RISK; CANCER SCREENING; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CHRONIC PANCREATITIS; CLINICAL ARTICLE; DISEASE SEVERITY; DIZZINESS; EARLY DIAGNOSIS; FAMILY HISTORY; FEMALE; HUMAN; JAUNDICE; MALE; PROGNOSIS; PROTEIN BLOOD LEVEL; SURVIVAL RATE; ULTRASOUND; WEAKNESS; WEIGHT REDUCTION;

EID: 79959328803     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2011.5.2.194     Document Type: Article

References (22)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-249.
2. Chang DK, Merrett ND, Biankin AV; NSW Pancreatic Cancer Network. Improving outcomes for operable pancreatic cancer: is access to safer surgery the problem? J Gastroenterol Hepatol 2008;23(7 Pt 1):1036-1045. (Pubitemid 352019387)
3. Chari ST. Detecting early pancreatic cancer: problems and prospects. Semin Oncol 2007;34:284-294. (Pubitemid 47176620)
4. Klapman J, Malafa MP. Early detection of pancreatic cancer: why, who, and how to screen. Cancer Control 2008;15:280-287.
5. Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004;350:1200-1210. (Pubitemid 38339364)
6. Brand RE, Lerch MM, Rubinstein WS, et al. Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut 2007;56:1460-1469. (Pubitemid 47517845)
7. Del Villano BC, Brennan S, Brock P, et al. Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9. Clin Chem 1983;29:549-552. (Pubitemid 13160773)
8. Larghi A, Verna EC, Lecca PG, Costamagna G. Screening for pancreatic cancer in high-risk individuals: a call for endoscopic ultrasound. Clin Cancer Res 2009;15:1907-1914.
9. Sohn TA, Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 2000;4:567-579.
10. Ariyama J, Suyama M, Ogawa K, et al. The detection and prognosis of small pancreatic carcinoma. Int J Pancreatol 1990;7:37-47.
11. Kern S, Hruban R, Hollingsworth MA, et al. A white paper: the product of a pancreas cancer think tank. Cancer Res 2001;61:4923-4932. (Pubitemid 32694386)
12. Vitone LJ, Greenhalf W, McFaul CD, Ghaneh P, Neoptolemos JP. The inherited genetics of pancreatic cancer and prospects for secondary screening. Best Pract Res Clin Gastroenterol 2006;20:253-283.
13. Canto MI. Strategies for screening for pancreatic adenocarcinoma in high-risk patients. Semin Oncol 2007;34:295-302. (Pubitemid 47176623)
14. Gullo L, Tomassetti P, Migliori M, Casadei R, Marrano D. Do early symptoms of pancreatic cancer exist that can allow an earlier diagnosis? Pancreas 2001;22:210-213.
15. Kim BJ, Lee KT, Moon TG, et al. How do we interpret an elevated carbohydrate antigen 19-9 level in asymptomatic subjects? Dig Liver Dis 2009;41:364-369.
16. Kim JE, Lee KT, Lee JK, Paik SW, Rhee JC, Choi KW. Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population. J Gastroenterol Hepatol 2004;19:182-186. (Pubitemid 38253358)
17. Lee JK. Screening and diagnosis for pancreatic cancer. Korean J Gastroenterol 2008;51:84-88.
18. Boeck S, Stieber P, Holdenrieder S, Wilkowski R, Heinemann V. Prognostic and therapeutic significance of carbohydrate antigen 19-9 as tumor marker in patients with pancreatic cancer. Oncology 2006;70:255-264.
19. Helmstaedter L, Riemann JF. Pancreatic cancer: EUS and early diagnosis. Langenbecks Arch Surg 2008;393:923-927.
20. American Gastroenterological Association medical position statement: epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. Gastroenterology 1999;117:1463-1484.
21. Holly EA, Chaliha I, Bracci PM, Gautam M. Signs and symptoms of pancreatic cancer: a population-based case-control study in the San Francisco Bay area. Clin Gastroenterol Hepatol 2004;2:510-517. (Pubitemid 38698368)
22. Khorana AA, Fine RL. Pancreatic cancer and thromboembolic disease. Lancet Oncol 2004;5:655-663. (Pubitemid 40267849)